Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Rotavirus (Bio Farma) Vaccine in Adults, Children & Neonates
NCT03462108Phase 1Completed
- Sponsor
- Bio Farma
- Start
- Apr 2018
- Primary completion
- Feb 2019
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of rotavirus vaccine 116E in rotavirus infection (4 arms), sponsored by Bio Farma. Primary endpoint: Solicited symptoms after each immunization. Started Apr 2018; status: completed.
02
Drugs
rotavirus vaccine 116E
03
Conditions
rotavirus infection
Beyond the preview
Go deeper on NCT03462108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03462108.